Abiopharma

Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million

Lucid Files Resale Prospectus Supplement

Newell Brands Declares Dividend on Common Stock

SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Tiendas 3B 2Q26 Earnings Release

Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress

INOVIO - INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

Longeveron - Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Intellinetics Reports Second Quarter and Six-Month 2026 Results